ScholarIQanswers from OpenAlex & ORCID
C Probert
ResearcherPublications, citations & collaboration network
C Probert is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does C Probert have?
ScholarIQindexed works
C Probert has 471 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does C Probert have?
ScholarIQcitation count
C Probert has 11,832 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of C Probert?
ScholarIQh-index
C Probert has an h-index of 56 in OpenAlex.
What is the i10-index of C Probert?
ScholarIQi10-index
C Probert has an i10-index of 180 in OpenAlex.
What is the ORCID of C Probert?
ScholarIQorcid
The ORCID for C Probert is on the source record.
What is the OpenAlex record for C Probert?
ScholarIQopenalex
The OpenAlex for C Probert is on the source record.
What are the most-cited papers on C Probert?
ScholarIQmost cited works
Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease
Maitreyi Raman, Iftikhar Ahmed, Patrick M. Gillevet, C Probert, Norman M. Ratcliffe, Steve Smith, Rosemary Greenwood, Masoumeh Sikaroodi, Victor L. Lam, Pam Crotty, Jennifer Bailey, Robert P. Myers, Kevin P. Rioux
Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease
Catherine E. Garner, Stephen J. Smith, Ben de Lacy Costello, Paul White, R.C. Spencer, C Probert, Norman M. Ratcliffem
Intestinal Enteroendocrine Lineage Cells Possess Homeostatic and Injury-Inducible Stem Cell Activity
Kelley S. Yan, Olivier Gevaert, Grace Zheng, Benedict Anchang, C Probert, Kathryn A. Larkin, Paige S. Davies, Zhuan-fen Cheng, John S. Kaddis, Arnold Han, Kelly Roelf, Ruben I. Calderon, Esther Cynn, Xiaoyi Hu, Komal Mandleywala, Julie Wilhelmy, Sue M. Grimes, David C. Corney, Stéphane C. Boutet, Jessica M. Terry, Phillip Belgrader, Solongo B. Ziraldo, Tarjei S. Mikkelsen, Fengchao Wang, Richard J. von Furstenberg, Nicholas R. Smith, Parthasarathy Chandrakesan, Randal May, Mary Ann S. Chrissy, Rajan Jain, Christine A. Cartwright, Joyce C. Niland, Young-Kwon Hong, Jill L. Carrington, David T. Breault, Jonathan A. Epstein, Courtney W. Houchen, John P. Lynch, Martı́n G. Martı́n, Sylvia K. Plevritis, Christina Curtis, Hanlee P. Ji, Linheng Li, Susan Henning, Melissa H. Wong, Calvin J. Kuo
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial
C Probert, S D Hearing, S Schreiber, T Kühbacher, S Ghosh, I D R Arnott, A Forbes
A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease
William J. Sandborn, William J. Sandborn, Subrata Ghosh, Julian Panes, Ivana Vranić, Wenjin Wang, Wojciech Niezychowski, Séverine Vermeire, Olivier Dewit, Harald Peeters, Jiřı́ Stehlı́k, Tomáš Vaňásek, David Laharie, Jean Frédéric Colombel, M A Bigard, Márta Varga, Margit Zeher, János Novák, Béla Hunyady, Á Salamon, I Rácz, Paolo Gionchetti, Anna Kohn, Cosimo Prantera, Pieter Stokkers, Maria Słomka, Leszek Paradowski, Tomasz Arłukowicz, L Kuzela, Boris Baricky, Tibor Hlavatý, María Isabel Vera-Muñoz, Julian Panes, Jordi Guardiola, C Probert, JL Shaffer, Mark Fleisher, Ronald Edward Pruitt, William J. Sandborn, William J. Sandborn, John S. Goff, John T. Weber, R. Bell, Andrew Zwick, Alexandra Gutierrez, Robert H. Levine, Stephen Brett Hanauer, Lori Ann Lavelle, Ravindranath Kottoor, Gerald Wayne Dryden, Robert Hardi, David Vaughn Glorioso, Prabhakar Swaroop, Scott D. Lee, Teressa Joan Patrick, Sheldon Scheinert, Charles A. Sninsky, Seymour Katz, Mark D. Noar, Marco Gaspari, Glenn L. Gordon, Thomas A. Dalton, Douglas Edward Homoky, William Ransom Kilgore, Joel A. Levien, Herbert R. Schneider, S. Moola, Frederik Cornelius Kruger, John Wright, Nazimuddin Aboo